SCHEMBL26664201

SCHEMBL26664201

CC(C)(C)OC(=O)N1CCC(c2nc3ccc(Br)cn3c2F)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.47
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
TSHR P16473 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CRHBP P24387 1/20 0.47
HTT P42858 1/20 0.47
CRHR2 Q13324 1/20 0.47
MAPT P10636 2/20 0.45
USP2 O75604 1/20 0.45
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TRPV3 Q8NET8 1/20 0.43
ENPP2 Q13822 1/20 0.43
THRB P10828 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207858 0.80 FPR2 (0.46) KDM4EMAPTGAATHRBFPR2
SCHEMBL7545748 0.79 GPR119 (0.45) HPGDKDM4EMEN1KMT2AHSD17B10
SCHEMBL26664203 0.78 TRPV3 (0.46) HPGDKDM4EALDH1A1TSHRMEN1
SCHEMBL30939393 0.76 FPR2 (0.44) KDM4EMAPTGAATRPV3THRB
SCHEMBL30939372 0.76 FPR2 (0.44) KDM4EMAPTGAATRPV3THRB
SCHEMBL26664280 0.75 MAPT (0.42) HPGDKDM4EALDH1A1TSHRMEN1
SCHEMBL18087305 0.74 KDM4E (0.43) HPGDKDM4EALDH1A1TSHRMEN1
SCHEMBL180505 0.73 NAMPT (0.60) KDM4EALDH1A1MAPTTHRBFPR2
SCHEMBL23294846 0.73 KDM1A (0.47) GPR119
SCHEMBL26930284 0.72 GPR119 (0.56) KDM4EMAPTTRPV3THRBFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111409-A1 HETEROCYCLIC COMPOUNDS OF FORMULA (I) FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY VIA MODULATION OF SMN2 SPLICING BIOGEN MA INC. (US) 2025-05-30 WO disclosed
CN-119866329-A Heterocyclic compounds for the treatment of huntington's disease 渤健马萨诸塞州股份有限公司 2025-04-22 CN disclosed
EP-4526292-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE Biogen MA Inc. (US) 2025-03-26 EP disclosed
WO-2023225244-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE BIOGEN MA INC. (US) 2023-11-23 WO disclosed